according to a May survey by KFF. Although drugs such as Ozempic originally were developed to treat chronic conditions such ...

Recent research has revealed that the diabetes drug tirzepatide outperforms other medications in both lowering blood sugar ...

Weight loss surgeries, GLP-1 drugs such as Wegovy, and lifestyle changes may all be able to boost brain health, though research varies. Most people know that obesity is linked to chronic ... a type of ...

Weight loss interventions could reduce the risk of severe cases of flu and other infections in people with diabetes, suggests ...

A new study shows people taking SGLT-2 inhibitors had fewer dementia cases than those taking DPP-4 inhibitors.

GLP-1 agonists may improve the disease course for a host of neurological and psychiatric disorders tied to inflammation, ...

These drugs work to treat diabetes and weight loss by suppressing the appetite and lowering blood sugar and A1C—which may end ...

in January found semaglutide was associated with a lower risk of suicidal thoughts compared to other anti-obesity and anti-diabetes drugs. The use of semaglutide for weight loss in Australia is ...

LMH Health, 325 Maine St., is pictured in May 2021. Commercials for diet and weight loss ... medications called GLP-1 antagonists, and were initially used for patients living with Type 2 diabetes.

Taking a weight loss drug may also help reduce ... lowers the risk of heart-related issues by up to 44% in people who are overweight or obese and without diabetes, according to a study published ...

Originally formulated to treat type 2 diabetes ... other weight-loss medications. Sanofi's Acomplia, which never won U.S. approval, was withdrawn in Europe in 2008 after being linked to suicidal ...

Novo Nordisk found evidence of compounded drugs with impurities or no semaglutide, according to a news release in May. The drug ... other weight loss and diabetes drugs cause harmful side effects ...